I think they have a very solid product, present in 30 countries and 8 jurisdictions. I saw this kind of performance with Novo Nordisk and I think OncoSil has a similar profile. Innovation + strong management/commercial strategy does it for me. It's going to become the new pancreatic cancer medication used everywhere. I see the current market consolidation phase as a buying strategy.
I think they have a very solid product, present in 30 countries...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.02 |
Change
0.065(6.84%) |
Mkt cap ! $14.43M | |||
| Open | High | Low | Value | Volume |
| $1.00 | $1.03 | 96.0¢ | $23.22K | 23.59K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15628 | 95.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.02 | 1042 | 1 |
View Market Depth
| Last trade - 14.07pm 18/06/2025 (20 minute delay) ? |
| OSL (ASX) Chart |